About Naia Rare Diseases
Naia Rare Diseases is a development-stage biopharmaceutical company developing novel drugs for rare gastrointestinal disorders.On November 13, 2019, Naia Rare Diseases was acquired by RDD Pharma. The terms of the transaction were not disclosed.
Missing: Naia Rare Diseases's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Naia Rare Diseases's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Naia Rare Diseases News
May 1, 2020
Naia Rare Diseases Frequently Asked Questions (FAQ)
When was Naia Rare Diseases founded?
Naia Rare Diseases was founded in 2014.
Where is Naia Rare Diseases's headquarters?
Naia Rare Diseases's headquarters is located at Richmond.
What is Naia Rare Diseases's latest funding round?
Naia Rare Diseases's latest funding round is Acquired.
Who are the investors of Naia Rare Diseases?
Investors of Naia Rare Diseases include RDD Pharma.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.